scispace - formally typeset
M

Márta Széll

Researcher at Hungarian Academy of Sciences

Publications -  78
Citations -  1706

Márta Széll is an academic researcher from Hungarian Academy of Sciences. The author has contributed to research in topics: Gene & Biology. The author has an hindex of 21, co-authored 59 publications receiving 1584 citations. Previous affiliations of Márta Széll include University of Szeged.

Papers
More filters
Journal ArticleDOI

Distinct Strains of Propionibacterium acnes Induce Selective Human β-Defensin-2 and Interleukin-8 Expression in Human Keratinocytes Through Toll-Like Receptors

TL;DR: The findings suggest that P. acnes modulates the antimicrobial peptide and chemokine expression of keratinocytes and thereby contributes to the recruitment of inflammatory cells to the sites of infections.
Journal ArticleDOI

Identification and characterization of a novel, psoriasis susceptibility-related noncoding RNA gene, PRINS.

TL;DR: Findings suggest that PRINS functions as a noncoding regulatory RNA, playing a protective role in cells exposed to stress, and elevated PRINS expression in the epidermis may contribute to psoriasis susceptibility.
Journal ArticleDOI

Microbial compounds induce the expression of pro-inflammatory cytokines, chemokines and human β-defensin-2 in vaginal epithelial cells

TL;DR: Evidence that microbial compounds induce the production of pro-inflammatory cytokines, chemokines and antimicrobial peptides in vaginal epithelial cells is provided.
Journal ArticleDOI

A 268 bp upstream sequence mediates the circadian clock-regulated transcription of the wheat Cab-1 gene in transgenic plants

TL;DR: Results indicate that the expression of the wheat Cab-1 gene is regulated mainly at the transcription level and identify a short promoter region between −211 and −90 that is responsible for the circadian clock-regulated gene expression.
Journal ArticleDOI

Human Keratinocytes Are Vanilloid Resistant

TL;DR: TRPV1B expression, together with low TRP V1 expression, may explain the vanilloid paradox: even genuinely TRPV 1 mRNA positive cells can be spared with therapeutic (up to micromolar) doses of RTX.